STOX1
Basic information
Region (hg38): 10:68827531-68895432
Previous symbols: [ "C10orf24" ]
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the STOX1 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 7 | |||||
missense | 49 | 57 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 1 | |||||
Total | 0 | 0 | 49 | 11 | 5 |
Variants in STOX1
This is a list of pathogenic ClinVar variants found in the STOX1 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
10-68827661-C-A | not specified | Uncertain significance (Oct 12, 2021) | ||
10-68827676-G-C | Benign (Jul 01, 2024) | |||
10-68827694-C-G | not specified | Uncertain significance (Jul 22, 2022) | ||
10-68827699-G-A | not specified | Uncertain significance (Nov 30, 2022) | ||
10-68827726-G-T | not specified | Uncertain significance (Dec 14, 2022) | ||
10-68827727-C-T | not specified | Uncertain significance (Dec 14, 2022) | ||
10-68827735-C-T | not specified | Uncertain significance (Jun 03, 2022) | ||
10-68827757-C-G | not specified | Uncertain significance (Dec 19, 2022) | ||
10-68827772-A-C | not specified | Uncertain significance (Jan 22, 2024) | ||
10-68827783-G-A | not specified | Uncertain significance (Jan 08, 2024) | ||
10-68827786-C-G | not specified | Uncertain significance (Mar 31, 2024) | ||
10-68827801-C-T | Likely benign (Mar 01, 2023) | |||
10-68827808-T-C | not specified | Uncertain significance (Jul 30, 2024) | ||
10-68827818-G-C | not specified | Uncertain significance (Nov 19, 2022) | ||
10-68827826-G-C | not specified | Uncertain significance (Mar 01, 2024) | ||
10-68827828-G-A | not specified | Uncertain significance (Apr 06, 2024) | ||
10-68827831-G-A | not specified | Uncertain significance (Sep 08, 2024) | ||
10-68827832-T-C | not specified | Uncertain significance (Jun 19, 2024) | ||
10-68827844-G-A | not specified | Likely benign (Sep 27, 2024) | ||
10-68827849-C-A | not specified | Uncertain significance (May 30, 2024) | ||
10-68827849-C-T | not specified | Uncertain significance (Jun 28, 2024) | ||
10-68827853-C-T | not specified | Uncertain significance (Dec 07, 2024) | ||
10-68827868-T-C | not specified | Uncertain significance (May 31, 2023) | ||
10-68828137-C-T | Likely benign (Mar 01, 2023) | |||
10-68882090-G-A | not specified | Likely benign (Jul 10, 2024) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
STOX1 | protein_coding | protein_coding | ENST00000298596 | 4 | 67891 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
1.44e-16 | 0.0829 | 124777 | 0 | 15 | 124792 | 0.0000601 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.336 | 438 | 458 | 0.956 | 0.0000235 | 6502 |
Missense in Polyphen | 94 | 99.141 | 0.94815 | 1621 | ||
Synonymous | -0.0254 | 168 | 168 | 1.00 | 0.00000899 | 1935 |
Loss of Function | 0.974 | 28 | 34.1 | 0.820 | 0.00000216 | 428 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00 | 0.00 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000389 | 0.000389 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.0000628 | 0.0000618 |
Middle Eastern | 0.000389 | 0.000389 |
South Asian | 0.0000327 | 0.0000327 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Involved in regulating the levels of reactive oxidative species and reactive nitrogen species and in mitochondrial homeostasis in the placenta (PubMed:24738702). Required for regulation of inner ear epithelial cell proliferation via the AKT signaling pathway (By similarity). {ECO:0000250|UniProtKB:B2RQL2, ECO:0000269|PubMed:24738702}.;
Recessive Scores
- pRec
- 0.106
Intolerance Scores
- loftool
- 0.645
- rvis_EVS
- 1.45
- rvis_percentile_EVS
- 95.14
Haploinsufficiency Scores
- pHI
- 0.0916
- hipred
- N
- hipred_score
- 0.212
- ghis
- 0.411
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.122
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Stox1
- Phenotype
Gene ontology
- Biological process
- cell cycle;positive regulation of cell population proliferation;regulation of gene expression;positive regulation of gene expression;negative regulation of gene expression;positive regulation of peptidyl-threonine phosphorylation;regulation of mitochondrion organization;positive regulation of G2/M transition of mitotic cell cycle;positive regulation of peptidyl-serine phosphorylation;inner ear development;positive regulation of epithelial cell proliferation;cell division;regulation of mitochondrial membrane potential;positive regulation of protein kinase B signaling;regulation of transcription from RNA polymerase II promoter in response to hypoxia;cellular response to nitrosative stress;regulation of mitochondrial DNA metabolic process;regulation of response to oxidative stress;positive regulation of cyclin-dependent protein kinase activity;positive regulation of otic vesicle morphogenesis
- Cellular component
- fibrillar center;nucleus;nucleoplasm;cytoplasm;centrosome;cytosol;cell cortex
- Molecular function
- RNA polymerase II regulatory region sequence-specific DNA binding;protein binding